Sanofi/麻豆视频APK Pharmacy Industry Fellowship Program

Sanofi/麻豆视频APK Industry Fellowship Program

Home - Academics - Nesbitt School of Pharmacy - Sanofi / 麻豆视频APK Pharmaceutical Industry Fellowship Program

The Sanofi and 麻豆视频APK University two-year Pharmaceutical Industry Fellowship Program offers Doctor of Pharmacy graduates a comprehensive experience. This program provides opportunities in various functional areas within multiple Global Business Units.

Fellowships Offered

Pharmacovigilance Fellowships

The Fellow will have the opportunity to rotate across the various Sanofi Global Business Units within Pharmacovigilance.

Pharmacovigilance Fellowship

US Medical Affairs Fellowship

The Fellow will have the opportunity to rotate across Sanofi Vaccines in multiple Medical Affairs areas, such as Field-Based Medical Team (Medical Science Liaison), Medical Strategy, Health Economics and Outcomes, and Omnichannel.

US Medical Affairs Fellowship

Periodic Safety Reports and Literature Surveillance Fellowship

The Fellow will have the opportunity to develop expertise in various pharmacovigilance operational activities including Periodic Safety Report (PSR) planning, PSR coordination and Literature Surveillance.

PERIODIC SAFETY REPORTS AND LITERATURE Surveillance FELLOWSHIP

Company Overview

Around the world, more than 100,000 people at Sanofi are dedicated to chasing the miracles of science to improve people鈥檚 lives. Our promise to our employees is to pursue progress and discover extraordinary together: better science, better medications, better outcomes. All that progress needs people. People from diverse backgrounds, in various places around the world, performing distinct roles all united by one thing: a desire to chase the miracles of science to improve people鈥檚 lives.

Our employees are people who:

Explore more, sharing our purpose and our skills.
Chase change and embrace innovative ideas.
Do right for our business, patients, society, and the planet. We are committed to making the right decision and taking action even when it is the harder thing to do.
Make miracles, taking thoughtful risks to find better solutions for the people we serve.

About Sanofi

Sanofi is structured with four Global Business Units to support the company鈥檚 Play to Win strategy:

Specialty Care
Vaccines
General Medicines
Consumer Healthcare (a standalone business unit)

As of July 2024, the R&D pipeline contained:

77 projects
30 projects are in phase 3 or have been submitted to regulatory authorities for approval

We are committed to high standards of manufacturing excellence and our people produce healthcare solutions to prevent and manage a broad spectrum of medical conditions.

鈧�1 billion invested annually in modernizing our supply network
170 countries served by our distribution operations
More than 4.8 billion units of pharmaceuticals, consumer healthcare products, and vaccines including those generated from in-house and outsourced production, sold annually

Our Journey in Vaccines

Sanofi has been a leader in vaccines for more than 100 years. The combination of our innovative vaccines and global reach means that many diseases do not hold the power they once did. Our determination to improve public health motivates us to develop new vaccines to address still unmet medical needs.

Fueled by new data and digital technologies, our science and manufacturing have the potential to transform the practice of medicine for millions of people around the world. And when we discover the extraordinary, we鈥檙e already planning where to go next. Because everyone deserves a chance to plan for their future, to dream big.

Our vaccines are available in ~150 countries

500 million people vaccinated annually with our vaccines, worldwide

2.5 million vaccine doses supplied, every day

鈧�1 billion invested in vaccines R&D each year

Our Journey in Specialty Care

As the Specialty Care Global Business Unit of Sanofi, our work is focused in the areas of rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. Each day we continue to advance new therapies, demonstrating our commitment to making a positive impact on the lives of patients around the world.

Specialty Care focuses on developing transformative specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families.

We are driven by our patient-focused science led approach and our ambition is to be the industry leader in Specialty Care. We currently provide more than 25 treatments to patients globally, with many potential new therapies being studied in clinical trials and in Sanofi laboratories. This is made possible by the significant expertise of market access professionals in countries and globally who are passionate about their mission.